High Tide (NASDAQ: HITI) German Subsidiary Showcases Canadian Medical Cannabis Partnerships at Major European Trade Show

2026-06-17, 4:01:05 a.m.

CALGARY, AB, June 17, 2026 — Leads & Copy — High Tide Inc. announced Tuesday that its majority-owned subsidiary, Remexian Pharma GmbH, successfully showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026. The event, one of Europe’s largest cannabis trade shows, took place from June 11–14, 2026, in Berlin, Germany.

Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to German patients and pharmacies, solidifying its position as a key importer and distributor in a rapidly expanding medical cannabis market.

At the trade show, Remexian featured medical cannabis products from Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals and Castle Rock Farms. The company highlighted its growing portfolio of exclusive brand distribution agreements, connecting these Canadian brands directly with pharmacies, healthcare professionals, patients and other stakeholders within Germany’s medical cannabis ecosystem.

Germany is recognized as a significant growth opportunity within the global medical cannabis industry. Remexian’s presence at Mary Jane Berlin underscored its role as a trusted importer and distributor of premium Canadian medical cannabis. The event also facilitated the expansion of Remexian’s pharmacy network and strengthened relationships with healthcare professionals and industry participants across the country.

“The response we received at Mary Jane Berlin reinforces what we are seeing across the German market: patients and healthcare professionals are actively seeking differentiated, high-quality cannabis products backed by trusted brands,” said Raj Grover, Founder and Chief Executive Officer of High Tide. “Through Remexian, we are bringing some of Canada’s most recognized and in-demand cannabis brands directly to this growing patient base. We believe our unmatched procurement capabilities and expanding portfolio of exclusive distribution agreements are creating a meaningful competitive advantage in Germany.”

Grover added, “By continuously broadening our product offering and strengthening relationships across the supply chain, we are positioning Remexian to capture an even larger share of one of the world’s most attractive medical cannabis markets. This is another example of how High Tide is leveraging its Canadian strengths to build a globally diversified cannabis platform with multiple avenues for long-term growth.”

High Tide, Inc. is a retail-forward cannabis enterprise. Its subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally, with 228 domestic and one international location. High Tide operates across all components of cannabis, including retail, with Canna Cabana as the largest cannabis retail chain in Canada. The company also owns and operates global e-commerce platforms for accessories and hemp-derived CBD products. High Tide was the first North American cannabis operator to launch a bricks-and-mortar presence in Germany in 2025.

Remexian Pharma GmbH is a German pharmaceutical company with a 14% share of the German medical cannabis market, focused on the importation and wholesale of medical cannabis products. Remexian is licensed to import from 19 countries, including Canada.

High Tide has been recognized for its growth, including being named one of Canada’s Top Growing Companies by the Globe and Mail’s Report on Business in 2025 for the fifth consecutive year. The company was also recognized by the TSX Venture Exchange (TSXV) in 2022, 2024, and 2025, and ranked number one in the retail category on the Financial Times list of Americas’ Fastest Growing Companies for 2023.

Source: High Tide Inc.

×

Welcome!

CannabisReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy

By Subscribing you will receive Daily Cannabis Story Leads via email 10:30 am ET Mon-Fri.